UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. (Exact Name of Registrant as Specified in its Charter) | Delaware | 86-1832801 | | --- | ...

Q3 2021 Earnings Presentation November 8, 2021 Forward-Looking Statements DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries ("LifeStance") and the industry in which LifeStance operates, including statements regarding future results of operations and financial position of LifeStance, which are subject to known and unknown uncertainties and contingencies outside of LifeStance's control ...

LifeStance Health Group, Inc. (NASDAQ:LFST) Q3 2021 Earnings Conference Call November 8, 2021 5:30 PM ET Company Participants Monica Prokocki - Vice President of Investor Relations Mike Lester - Chairman, President and Chief Executive Officer Mike Bruff - Chief Financial Officer Danish Qureshi - Chief Growth Officer Conference Call Participants Ricky Goldwasser - Morgan Stanley. Lisa Gill - JPMorgan Ryan Daniels - William Blair Kevin Caliendo - UBS Steph Wissink - Jefferies Disclaimer*: This transcript is d ...

Financial Performance - Revenue for Q2 2021 was $160.5 million, a 91% increase year-over-year compared to $84.0 million in Q2 2020[7] - Adjusted EBITDA for Q2 2021 was $14.5 million, a 39% increase year-over-year compared to $10.5 million in Q2 2020[7] - The company has a strong balance sheet with a cash position of $276 million[7] - TTM (Trailing Twelve Months) Revenue is $524 million[8] Growth and Expansion - Total clinicians reached 3,975, up 94% year-over-year, with 674 net clinician additions in Q2 2021[7] - The company operates in 31 states with 450+ centers[10, 16, 18] - 35 de novo centers were opened in Q2 2021, part of 183 opened since inception[16] - 10 acquisitions were completed in Q2 2021, part of 64 acquisitions completed since inception[16] Market and Strategy - The company is well-positioned for continued market share gains in the $116 billion mental health market[10] - The company estimates the total addressable market (TAM) will grow to $215 billion by 2025, representing a 14% CAGR (Compound Annual Growth Rate)[17] Social Responsibility - The LifeStance Health Foundation was established with an initial endowment of $10 million[7, 13]

LifeStance Health Group, Inc. (NASDAQ:LFST) Q2 2021 Earnings Conference Call August 11, 2021 5:00 PM ET Company Participants Michael Lester - Chief Executive Officer Danish Qureshi - Chief Growth Officer Mike Bruff - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Ryan Daniels - William Blair Lisa Gill - JPMorgan Steph Wissink - Jefferies Jamie Perse - Goldman Sachs Operator Good afternoon everyone and welcome to LifeStance Health Second Quarter 2021 Conference Call. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. (Exact Name of Registrant as Specified in its Charter) | Delaware | 86-1832801 | | --- | --- | ...